Sleep Is the Most Important Hormone You're Not Measuring

Sleep is described clinically as a physiological need — the same category as nutrition and hydration. This framing is accurate but incomplete. Sleep is also a hormonal event. The quality and architecture of sleep directly determines the production and regulation of multiple hormones. And hormonal imbalances, in turn, directly disrupt sleep. Understanding both directions of this relationship changes how sleep problems — and hormone problems — should be approached.

What happens hormonally during sleep

Sleep is not a passive state. It is an active, structured biological process with distinct phases — NREM stages 1-3 (non-rapid eye movement, progressing from light to deep slow-wave sleep) and REM sleep — that repeat in 90-minute cycles throughout the night.

Testosterone and growth hormone. Both testosterone and growth hormone are released primarily during slow-wave sleep (NREM stage 3). Growth hormone's largest daily pulse occurs in the first two hours of sleep, during the first slow-wave episode. Testosterone rises during REM sleep in the second half of the night. Disrupting either phase of sleep — through sleep apnea, alcohol, late-night blue light, or irregular sleep timing — directly reduces the hormone secreted during that phase.

One night of sleep restriction to five hours reduces testosterone levels in healthy young men by 10-15%. Extended sleep disruption produces more sustained effects. For patients who are already at the lower end of normal testosterone, chronic poor sleep may be a meaningful contributor to their deficiency picture.

Cortisol. The cortisol rhythm is a key driver of sleep architecture. Cortisol should be lowest in the evening, facilitating sleep onset, and rise sharply in the early morning (cortisol awakening response). When this pattern is disrupted — elevated evening cortisol, a flattened curve, or secondary peaks in the middle of the night — sleep suffers in predictable ways: difficulty falling asleep, frequent waking, and early morning arousal with inability to return to sleep.

Progesterone. Progesterone and its metabolite allopregnanolone have direct GABAergic activity in the brain — the same inhibitory mechanism targeted by benzodiazepines and sleep medications. Progesterone decline in perimenopause directly impairs sleep initiation and maintenance. This is not a coincidental association; it is a mechanistic one. Progesterone restoration — at appropriate physiological doses — often improves sleep more effectively and more durably than pharmacological sleep aids.

Insulin sensitivity and sleep

This relationship surprises many patients. A single night of sleep restriction to four to five hours produces insulin resistance equivalent to months of dietary deterioration in some studies. The mechanism involves cortisol and growth hormone disruption as well as direct effects on peripheral glucose uptake.

The clinical implication: patients who report poor metabolic response to diet and exercise intervention should have their sleep quality assessed alongside their hormonal and metabolic panel. Addressing sleep disruption may be prerequisite to meaningful improvement in other metabolic parameters.

The glymphatic system

The brain has a waste clearance system — the glymphatic system — that operates primarily during deep slow-wave sleep. During this phase, cerebrospinal fluid flows through channels alongside blood vessels in the brain, clearing metabolic byproducts including amyloid-beta and tau proteins — the substances associated with neurodegenerative disease. Chronic disruption of slow-wave sleep impairs this clearance mechanism over time.

This is one reason why poor sleep is increasingly recognized as a risk factor for cognitive decline — not just a consequence of it.

When poor sleep is a symptom versus the primary problem

The clinical distinction is important. Insomnia driven primarily by hormonal deficiency (progesterone decline, elevated evening cortisol, testosterone-related sleep apnea) will not respond adequately to behavioral interventions alone. Sleep hygiene and cognitive behavioral therapy for insomnia (CBT-I) are appropriate for behaviorally-driven insomnia — not for physiologically-driven disruption.

Conversely, addressing hormonal deficiency alone may not fully resolve sleep problems when there are concurrent behavioral drivers, chronic circadian disruption, or untreated sleep apnea.

The practical starting point is a comprehensive hormonal and metabolic evaluation that explicitly includes sleep quality as a symptom — not as an afterthought. From that foundation, the appropriate intervention becomes clear.